Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Respair develops and manufactures airway management devices, such as the RelianceET, aimed at improving clinical workflows and patient outcomes for ventilated patients in critical care settings. The company is based in Pittsburgh.
0 investors
0 investors
0 investors
0 investors
Responsive Arthroscopy develops medical devices for sports medicine applications. The company is based in Minneapolis and focuses on improving patient outcomes while reducing healthcare costs.
0 investors
0 investors
0 investors
Retain Health builds software that guides individuals to adopt brain-healthy habits through personalized, evidence-based recommendations aimed at reducing the risk of Alzheimer's disease. Its non-invasive tools focus on behavior change and prevention education, designed to scale across broad populations.
0 investors
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for hypertension and cardiovascular disease. The company's lead compound, RTN-001, is a tissue-targeted PDE5 inhibitor designed to treat resistant hypertension through a differentiated mechanism targeting the central pulmonary vasculature.
0 investors
Retham Technologies develops diagnostic assays for heparin-induced thrombocytopenia (HIT) and related blood disorders. The company serves clinical laboratories and healthcare systems with in vitro diagnostic tests.
0 investors
0 investors
0 investors
Retrieve Medical develops AI-powered documentation and administrative tools for healthcare providers to reduce documentation burden and improve clinical efficiency. The company combines clinical expertise with machine learning to help providers capture comprehensive patient care records.
0 investors
Retropsoas Technologies develops innovative surgical solutions for spine surgery that combine multiple surgical techniques to improve patient outcomes while minimizing tissue disruption.
0 investors
0 investors
RevBio Sciences develops Gemini, an intravenously administered formulation of phosphorylated hexaacyl disaccharide (PHAD) designed to reduce inflammation-related damage by reprogramming the innate immune system to respond to stress such as trauma and infection in an attenuated way. The company works in therapeutics and immunology.
0 investors
Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.
0 investors